Show
Sort by
-
Continuous infusion piperacillin in critically ill patients: predicting concentrations using published population pharmacokinetic models
-
Impact of AST meetings on antimicrobial therapy decisions in the ICU
-
Target attainment of empirically dosed continuous infusion of piperacillin/tazobactam and meropenem in critically ill patients
-
Development of a multivariate prediction model for mortality in a cohort of 1177 critically ill patients with hypoxic hepatitis
-
Population pharmacokinetics of continuous infusion piperacillin in critically ill patients
-
Epidemiology, cause, evolution and outcome in a cohort of 1177 critically ill patients with hypoxic hepatitis
-
Early diagnosis of AKI in the ICU: urinary chitinase 3-like protein 1 as a novel renal troponin